Neoplasms

Oncology·MeSH: Neoplasms

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

256 drugs in development·53 companies·32 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
levoleucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
zaltrap	Sanofi (SNY)

Phase 3(101)

Drug	Company
177lu-psma-617	Novartis AG (NVS)
177Lu-PSMA-617	Novartis AG (NVS)
5-fu	PFIZER INC (PFE)
abiraterone	CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
abiraterone	GH Research PLC (GHRS)
Abiraterone acetate	Merck & Co., Inc. (MRK)
Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
adt	Novartis AG (NVS)
Amivantamab	Amneal Pharmaceuticals, Inc. (AMRX)
Amivantamab	REGENXBIO Inc. (RGNX)
Amivantamab and Recombinant Human Hyaluronidase	Amneal Pharmaceuticals, Inc. (AMRX)
Androgen-deprivation Therapy	Myovant Sciences Ltd. (MYOV)
Apalutamide	Myovant Sciences Ltd. (MYOV)
Apalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Apalutamide 60 mg or 240 mg tablets	KYNTRA BIO INC. (KYNB)
ardt	Novartis AG (NVS)
ARDT	Novartis AG (NVS)
AZD2962	ASTRAZENECA PLC (AZN)
Belrestotug	iTeos Therapeutics, Inc. (ITOS)
belrestotug (EOS-448/GSK4428859A)	iTeos Therapeutics, Inc. (ITOS)
bezuclastinib (CGT9486)	Cogent Biosciences, Inc. (COGT)
Bicalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Cabazitaxel	Merck & Co., Inc. (MRK)
Camrelizumab and Cetuximab	Amneal Pharmaceuticals, Inc. (AMRX)
cetrelimab	GH Research PLC (GHRS)
Cetrelimab	KYNTRA BIO INC. (KYNB)
Cetrelimab	CG Oncology, Inc. (CGON)
cetuximab	GH Research PLC (GHRS)
Cetuximab	Merck & Co., Inc. (MRK)
Cetuximab	REGENXBIO Inc. (RGNX)
Cetuximab	Amneal Pharmaceuticals, Inc. (AMRX)
Conventional NSAA	KYNTRA BIO INC. (KYNB)
Darolutamide	ARS Pharmaceuticals, Inc. (SPRY)
Darolutamide	Merus N.V. (MRUS)
Darolutamide	ELI LILLY & Co (LLY)
Dostarlimab	iTeos Therapeutics, Inc. (ITOS)
eflornithine plus sulindac	GH Research PLC (GHRS)
eltanexor	Karyopharm Therapeutics Inc. (KPTI)
Enzalutamide	Myovant Sciences Ltd. (MYOV)
Epirubicin	Merus N.V. (MRUS)
Epirubicin	Merck & Co., Inc. (MRK)
Epirubicin Hydrochloride	Merck & Co., Inc. (MRK)
Floxuridine	IGM Biosciences, Inc. (IGMS)
Fludrocortisone acetate	Merck & Co., Inc. (MRK)
folfiri	GH Research PLC (GHRS)
folfiri	Sanofi (SNY)
GnRH	ARS Pharmaceuticals, Inc. (SPRY)
GnRH Agonist	Myovant Sciences Ltd. (MYOV)
Hydrocortisone	Merck & Co., Inc. (MRK)
Imlunestrant + Goserelin	ELI LILLY & Co (LLY)
inca033989	Incyte Corp. (INCY)
inca035784	Incyte Corp. (INCY)
inca036978	Incyte Corp. (INCY)
Intismeran autogene	Merck & Co., Inc. (MRK)
Ivosidenib	AGIOS PHARMACEUTICALS, INC. (AGIO)
JNJ-56021927	ARS Pharmaceuticals, Inc. (SPRY)
jnj-78278343	GH Research PLC (GHRS)
jnj-86974680	GH Research PLC (GHRS)
jnj-87189401	GH Research PLC (GHRS)
leucovorin calcium/levoleucovorin	GH Research PLC (GHRS)
Leucovorin calcium/Levoleucovorin	REGENXBIO Inc. (RGNX)
LHRHa	Myovant Sciences Ltd. (MYOV)
LHRHA	KYNTRA BIO INC. (KYNB)
LY4064809	Merus N.V. (MRUS)
LY4064809	ELI LILLY & Co (LLY)
MIRV	ELI LILLY & Co (LLY)
MIRV	Merus N.V. (MRUS)
mitomycin c	GH Research PLC (GHRS)
MMC	Merus N.V. (MRUS)
momelotinib	GH Research PLC (GHRS)
New Formulation of Niraparib and Abiraterone Acetate	Janux Therapeutics, Inc. (JANX)
New Formulation of Niraparib and Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
niraparib	TESARO, Inc. (TSRO)
niraparib	GH Research PLC (GHRS)
Niraparib	Janux Therapeutics, Inc. (JANX)
Niraparib	Myovant Sciences Ltd. (MYOV)
Olaparib	Merck & Co., Inc. (MRK)
ONC206	Jazz Pharmaceuticals plc (JAZZ)
Opevesostat	Merck & Co., Inc. (MRK)
pasritamig	GH Research PLC (GHRS)
Patritumab deruxtecan	Merck & Co., Inc. (MRK)
Pemetrexed	KYNTRA BIO INC. (KYNB)
Pertuzumab	ASTRAZENECA PLC (AZN)
Pertuzumab	Merck & Co., Inc. (MRK)
platinum	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
platinum	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Remzistotug	iTeos Therapeutics, Inc. (ITOS)
Sacituzumab tirumotecan	Merus N.V. (MRUS)
Sofetabart Mipitecan	Merus N.V. (MRUS)
Sofetabart Mipitecan	ELI LILLY & Co (LLY)
Standard Adjuvant Endocrine Therapy	PFIZER INC (PFE)
Taletrectinib	Nuvation Bio Inc. (NUVB)
tar-200	GH Research PLC (GHRS)
TAR-200	Merus N.V. (MRUS)
TAR-200	CG Oncology, Inc. (CGON)
tar-210	GH Research PLC (GHRS)
TAR-210	Merus N.V. (MRUS)
Temozolomide	BRISTOL MYERS SQUIBB CO (BMY)
Tislelizumab	Jazz Pharmaceuticals plc (JAZZ)
Tucatinib	PFIZER INC (PFE)
Vinblastine	ASTRAZENECA PLC (AZN)

Phase 2(42)

Drug	Company
-endoxifen	ATOSSA THERAPEUTICS, INC. (ATOS)
350 mg leronlimab	CytoDyn Inc. (CYDY)
525 mg leronlimab	CytoDyn Inc. (CYDY)
68ga-psma-11	Novartis AG (NVS)
68Ga-PSMA-11	Novartis AG (NVS)
700 mg leronlimab	CytoDyn Inc. (CYDY)
ADT	Novartis AG (NVS)
Apalutamide	ENANTA PHARMACEUTICALS INC (ENTA)
BCG	Merck & Co., Inc. (MRK)
Bezuclastinib	Cogent Biosciences, Inc. (COGT)
bridging therapy	GH Research PLC (GHRS)
Cabazitaxel	Janux Therapeutics, Inc. (JANX)
CAR BCMA-CD70-T cells	Filana Therapeutics Inc. (FLNA)
CAR BCMA-CD70-T cells	Merus N.V. (MRUS)
Cetrelimab	Merus N.V. (MRUS)
Cetrelimab	Royalty Pharma plc (RPRX)
cetuximab	PFIZER INC (PFE)
disitamab vedotin	PFIZER INC (PFE)
Eribulin	BioNTech SE (BNTX)
Feladilimab	iTeos Therapeutics, Inc. (ITOS)
Flotufolastat F18	Valneva SE (VALN)
GnRH Agonist	Royalty Pharma plc (RPRX)
GnRH Agonist	Janux Therapeutics, Inc. (JANX)
GNRH-A Goserelin	ELI LILLY & Co (LLY)
goserelin	ELI LILLY & Co (LLY)
goserelin	ATOSSA THERAPEUTICS, INC. (ATOS)
GSK4428859A	iTeos Therapeutics, Inc. (ITOS)
GSK6097608	iTeos Therapeutics, Inc. (ITOS)
incb160058	Incyte Corp. (INCY)
Iza-bren	Merus N.V. (MRUS)
JNJ-63723283	Janux Therapeutics, Inc. (JANX)
leucovorin	KYNTRA BIO INC. (KYNB)
morab-202	BRISTOL MYERS SQUIBB CO (BMY)
novel hormonal therapy	PFIZER INC (PFE)
Oleclumab	ASTRAZENECA PLC (AZN)
Ramucirumab	PTC THERAPEUTICS, INC. (PTCT)
Ramucirumab	ELI LILLY & Co (LLY)
TAR-200	Janux Therapeutics, Inc. (JANX)
Temozolomide	ELI LILLY & Co (LLY)
topotecan	BRISTOL MYERS SQUIBB CO (BMY)
Vinorelbine	PTC THERAPEUTICS, INC. (PTCT)
Vinorelbine	ELI LILLY & Co (LLY)

Phase 1(73)

Drug	Company
[68ga]ga-dwj155	Novartis AG (NVS)
Ami-HC	Structure Therapeutics Inc. (GPCR)
Ami-HC-CF	Structure Therapeutics Inc. (GPCR)
Ami-LC	Structure Therapeutics Inc. (GPCR)
Ami-LC-MD	Structure Therapeutics Inc. (GPCR)
Apalutamide	Merus N.V. (MRUS)
Apalutamide	Janux Therapeutics, Inc. (JANX)
aza-TdC	Arbutus Biopharma Corp (ABUS)
Belrestotug	ANAPTYSBIO, INC (ANAB)
BI 836845	KYNTRA BIO INC. (KYNB)
Bridging Therapy	Janux Therapeutics, Inc. (JANX)
Cabazitaxel	Royalty Pharma plc (RPRX)
Cabazitaxel	Merus N.V. (MRUS)
Cabazitaxel	ARS Pharmaceuticals, Inc. (SPRY)
Cabazitaxel	Myovant Sciences Ltd. (MYOV)
cetrelimab	Innovation Pharmaceuticals Inc. (IPIX)
cetrelimab	JOHNSON & JOHNSON (JNJ)
Cetrelimab	ARS Pharmaceuticals, Inc. (SPRY)
Cetrelimab	Myovant Sciences Ltd. (MYOV)
Cobolimab	iTeos Therapeutics, Inc. (ITOS)
E7389-LF	ENANTA PHARMACEUTICALS INC (ENTA)
elacestrant	STEMLINE THERAPEUTICS INC (STML)
enfortumab vedotin	ELI LILLY & Co (LLY)
Enzalutamide	Janux Therapeutics, Inc. (JANX)
felmetatug vedotin	PFIZER INC (PFE)
GSK4418959	IDEAYA Biosciences, Inc. (IDYA)
GSK5764227	KYNTRA BIO INC. (KYNB)
GSK6097608	ANAPTYSBIO, INC (ANAB)
hdp-101	NYMOX PHARMACEUTICAL CORP (NYMXF)
hdp-101	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
idrx-42	GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
Imlunestrant	ELI LILLY & Co (LLY)
jnj-101556143	GH Research PLC (GHRS)
jnj-1761981	JOHNSON & JOHNSON (JNJ)
jnj-1761981	Innovation Pharmaceuticals Inc. (IPIX)
jnj-69086420	GH Research PLC (GHRS)
jnj-75229414	GH Research PLC (GHRS)
JNJ-75229414	Janux Therapeutics, Inc. (JANX)
JNJ-75229414	Filana Therapeutics Inc. (FLNA)
JNJ-75229414	KYNTRA BIO INC. (KYNB)
JNJ-75229414	Merus N.V. (MRUS)
JNJ-78278343	ARS Pharmaceuticals, Inc. (SPRY)
JNJ-78278343	Myovant Sciences Ltd. (MYOV)
JNJ-78278343	KYNTRA BIO INC. (KYNB)
JNJ-78278343	Merus N.V. (MRUS)
JNJ-78278343	Janux Therapeutics, Inc. (JANX)
JNJ-78278343	Royalty Pharma plc (RPRX)
jnj-87704916	JOHNSON & JOHNSON (JNJ)
jnj-87704916	Innovation Pharmaceuticals Inc. (IPIX)
JNJ-87704916	Janux Therapeutics, Inc. (JANX)
jnj-88549968	GH Research PLC (GHRS)
jnj-89402638	GH Research PLC (GHRS)
jnj-95298177	GH Research PLC (GHRS)
JNJ-95298177	Janux Therapeutics, Inc. (JANX)
jnj-95437446	GH Research PLC (GHRS)
jnj-95804306	GH Research PLC (GHRS)
leucovorin	PFIZER INC (PFE)
LHRH agonist/antagonist	ELI LILLY & Co (LLY)
loxo-435	ELI LILLY & Co (LLY)
ly3484356	ELI LILLY & Co (LLY)
LY4214835	ELI LILLY & Co (LLY)
LY4257496	ELI LILLY & Co (LLY)
LY4337713	ELI LILLY & Co (LLY)
PD-1 inhibitor	IDEAYA Biosciences, Inc. (IDYA)
pf-08046050	PFIZER INC (PFE)
pf-08046052	PFIZER INC (PFE)
Pumitamig	Merus N.V. (MRUS)
QLH12016	KYNTRA BIO INC. (KYNB)
standard disease-directed therapy	Incyte Corp. (INCY)
TdCyd	Arbutus Biopharma Corp (ABUS)
Topotecan	ELI LILLY & Co (LLY)
Tucatinib	Merck & Co., Inc. (MRK)
TVB-2640	KYNTRA BIO INC. (KYNB)

Preclinical(3)

Drug	Company
cpi-482	CONSTELLATION PHARMACEUTICALS INC (CNST)
ht-kit	Hoth Therapeutics, Inc. (HOTH)
JAK2 program	Cogent Biosciences, Inc. (COGT)

Unknown(3)

Drug	Company
Abiraterone acetate	Janux Therapeutics, Inc. (JANX)
et mono ± lhrh	Novartis AG (NVS)
et mono ± lhrh	NOVARTIS AG (NVSEF)

N/A(1)

Drug	Company
GLP-1 receptor agonist	ELI LILLY & Co (LLY)

Phase 1/Phase 2(10)

Drug	Company
[177lu]lu-nns309	Novartis AG (NVS)
CRN09682	Crinetics Pharmaceuticals, Inc. (CRNX)
dazostinag	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
dazostinag	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Enzalutamide	Arcus Biosciences, Inc. (RCUS)
jnj-63723283	GH Research PLC (GHRS)
modakafusp alfa	Teva Pharmaceutical Industries Limited (TEVA)
nenocorilant	CORCEPT THERAPEUTICS INC (CORT)
Pumitamig	BioNTech SE (BNTX)
tisotumab vedotin	PFIZER INC (PFE)

Phase 2/Phase 3(2)

Drug	Company
[18f]ctt1057	Novartis AG (NVS)
iza-bren	BRISTOL MYERS SQUIBB CO (BMY)

Phase 4(19)

Drug	Company
abiraterone	PFIZER INC (PFE)
Abiraterone	KYNTRA BIO INC. (KYNB)
Abiraterone acetate	KYNTRA BIO INC. (KYNB)
Abiraterone acetate 250 mg or 500 mg tablets	KYNTRA BIO INC. (KYNB)
androgen deprivation therapy	GH Research PLC (GHRS)
Androgen receptor inhibitor	KYNTRA BIO INC. (KYNB)
Androgen Receptor Pathway Inhibitors	KYNTRA BIO INC. (KYNB)
Androgen Receptor Signal Inhibitor	KYNTRA BIO INC. (KYNB)
Androgen Receptor Signalling Inhibitor	KYNTRA BIO INC. (KYNB)
androgen-deprivation therapy	GH Research PLC (GHRS)
Androgen-deprivation Therapy	Janux Therapeutics, Inc. (JANX)
Apalutamide	KYNTRA BIO INC. (KYNB)
Bicalutamide	KYNTRA BIO INC. (KYNB)
bms-986213	BRISTOL MYERS SQUIBB CO (BMY)
Darolutamide	KYNTRA BIO INC. (KYNB)
Dexmedetomidine Injection [Precedex]	COGNITION THERAPEUTICS INC (CGTX)
Enzalutamide	Royalty Pharma plc (RPRX)
Relatlimab	BRISTOL MYERS SQUIBB CO (BMY)
Xeloda	IGM Biosciences, Inc. (IGMS)

Compare drugs

levoleucovorin vs zaltrap levoleucovorin vs 177lu-psma-617 levoleucovorin vs 5-fu

Frequently asked questions

How many drugs are in development for Neoplasms?

BioSniper tracks 256 drugs in development for Neoplasms across 53 companies.

How many clinical trials target Neoplasms?

There are 32 clinical trials targeting Neoplasms tracked by BioSniper.

What is the prevalence of Neoplasms?

The estimated prevalence of Neoplasms is approximately 287.0 per 100,000 population.

Deep-dive into Neoplasms

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis